Matěj Škorvánek

2.8k total citations
56 papers, 995 citations indexed

About

Matěj Škorvánek is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Matěj Škorvánek has authored 56 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 10 papers in Epidemiology. Recurrent topics in Matěj Škorvánek's work include Parkinson's Disease Mechanisms and Treatments (34 papers), Neurological disorders and treatments (19 papers) and Restless Legs Syndrome Research (10 papers). Matěj Škorvánek is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (34 papers), Neurological disorders and treatments (19 papers) and Restless Legs Syndrome Research (10 papers). Matěj Škorvánek collaborates with scholars based in Slovakia, Netherlands and Czechia. Matěj Škorvánek's co-authors include Zuzana Gdovinová, Jitse P. van Dijk, Jaroslav Rosenberger, Johan W. Groothoff, Iveta Nagyová, Kailash P. Bhatia, Pablo Martínez‐Martín, Glenn T. Stebbins, Christopher G. Goetz and Vladimír Haň and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neurology Neurosurgery & Psychiatry and Movement Disorders.

In The Last Decade

Matěj Škorvánek

53 papers receiving 983 citations

Peers

Countries citing papers authored by Matěj Škorvánek

Since Specialization

Citations

This map shows the geographic impact of Matěj Škorvánek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matěj Škorvánek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matěj Škorvánek more than expected).

Fields of papers citing papers by Matěj Škorvánek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matěj Škorvánek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matěj Škorvánek. The network helps show where Matěj Škorvánek may publish in the future.

Co-authorship network of co-authors of Matěj Škorvánek

This figure shows the co-authorship network connecting the top 25 collaborators of Matěj Škorvánek. A scholar is included among the top collaborators of Matěj Škorvánek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matěj Škorvánek. Matěj Škorvánek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How leaky is the gut in Parkinson’s disease? 2025 ·EBioMedicine ·Pascal Derkinderen, François Cossais, (unknown), Matěj Škorvánek, (unknown), Emmanuel Coron, Laurène Leclair‐Visonneau, Silvia Cerri, Carolina Pellegrini, Malvyne Rolli‐Derkinderen	1
2	Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations 2025 ·Movement Disorders ·Roberta Biundo, Ondřej Bezdíček, Davide Maria Cammisuli, Brenna Cholerton, John C. Dalrymple‐Alford, Nicola M.J. Edelstyn, Eleonora Fiorenzato, (unknown), Saül Martínez‐Horta, Alice Martini, Gabriella Santangelo, Bàrbara Segura, Chiara Siri, Alexander I. Tröster, Tiago Mestre, Álvaro Sánchez‐Ferro, (unknown), Matěj Škorvánek, Daniel Weintraub, Gert J. Geurtsen	0
3	Clinical Outcome Assessments for Spasticity: Review, Critique, and Recommendations 2024 ·Movement Disorders ·(unknown), Marjolaine Baude, Thierry Deltombe, Alberto Esquenazi, Jean‐Michel Graciès, Martina Hoskovcová, Carmen Rodríguez‐Blázquez, Raymond L. Rosales, (unknown), Jörg Wissel, Tiago Mestre, Álvaro Sánchez‐Ferro, Matěj Škorvánek, (unknown), Robert Jech	3
4	Endoscopic Complications Are More Frequent in Levodopa–Carbidopa Intestinal Gel Treatment via JET-PEG in Parkinson’s Disease Patients Compared to Nutritional PEG in Non-Parkinson’s Disease Patients 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Ivana Jochmanová, (unknown), Eduard Veselíny, (unknown), Vladimír Haň, (unknown), (unknown), (unknown), (unknown), (unknown), Ivica Lazúrová, Matěj Škorvánek	1
5	Slovak database of speech affected by neurodegenerative diseases 2024 ·Scientific Data ·(unknown), (unknown), (unknown), Alfréd Zimmermann, (unknown), (unknown), (unknown), (unknown), Matěj Škorvánek	0
6	Functional neurological disorder: a comparative analysis of experience of Czech, Slovak, and Italian neurologists 2024 ·Neurologia i Neurochirurgia Polska ·(unknown), Mirta Fiorio, (unknown), (unknown), Matěj Škorvánek, Evžen Růžička, Michèle Tinazzi, Tereza Serranová	2
7	Predictors of whole exome sequencing in dystonic cerebral palsy and cerebral palsy-like disorders 2023 ·Parkinsonism & Related Disorders ·Petra Pavelekova, Ján Necpál, Robert Jech, Petra Havránková, (unknown), (unknown), Zuzana Gdovinová, (unknown), Vladimír Haň, Juliane Winkelmann, Michael Zech, Matěj Škorvánek	2
8	Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations 2022 ·Movement Disorders Clinical Practice ·(unknown), Beatriz Guitton Renaud Baptista de Oliveira, Christopher G. Goetz, Donald E. Morisky, (unknown), Matěj Škorvánek, Anette Schrag, Pablo Martínez‐Martín, Glenn T. Stebbins	2
9	Prevalence of Fabry Disease among Patients with Parkinson’s Disease 2022 ·Parkinson s Disease ·(unknown), Christian Beetz, (unknown), Peter Bauer, Petra Pavelekova, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Zuzana Gdovinová, Vladimír Haň, Mie Rizig, Henry Houlden, Matěj Škorvánek	3
10	Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries 2022 ·BMC Neurology ·Irene A. Malaty, Pablo Martínez‐Martín, К. Ray Chaudhuri, Per Odin, Matěj Škorvánek, Joohi Jimenez‐Shahed, Michael J. Soileau, (unknown), Josefa Domingos, Sarah Jones, Ali Alobaidi, Yash J. Jalundhwala, (unknown), Koray Onuk, Lars Bergmann, (unknown), Michelle Y. Lee, (unknown), Angelo Antonini	24
11	Update on the Management of Parkinson’s Disease for General Neurologists 2020 ·Parkinson s Disease ·Zvezdan Pirtošek, Ovidiu Băjenaru, Norbert Kovács, Ivan Milanov, Maja Relja, Matěj Škorvánek	46
12	Prevalence of non‐motor symptoms and their association with quality of life in cervical dystonia 2020 ·Acta Neurologica Scandinavica ·Vladimír Haň, Matěj Škorvánek, (unknown), (unknown), Tialda Hoekstra, Jitse P. van Dijk, Marina A.J. Tijssen, Zuzana Gdovinová, Sijmen A. Reijneveld	23
13	Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia 2020 ·Parkinsonism & Related Disorders ·Michael Zech, Theresa Brunet, Matěj Škorvánek, Astrid Blaschek, Katharina Vill, (unknown), Irina Hüning, Vladimír Haň, (unknown), Zuzana Gdovinová, Bader Alhaddad, Riccardo Berutti, Tim M. Strom, Evžen Růžička, Erik‐Jan Kamsteeg, Jasper J. van der Smagt, Matias Wagner, Robert Jech, Juliane Winkelmann	4
14	Neuromodulation Options and Patient Selection for Parkinson's Disease 2020 ·Neurology India ·(unknown), Roopa Rajan, Matěj Škorvánek, (unknown), Junaid Siddiqui, (unknown), (unknown), (unknown), (unknown), Milind Deogaonkar	4
15	Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication 2019 ·Frontiers in Neurology ·(unknown), Michal Minár, Matěj Škorvánek, Milan Grofik, (unknown), Ján Benetin, Egon Kurča, Andrea Gažová, (unknown), Kathryn A Wyman‐Chick, Ján Kyselovič, (unknown)	36
16	Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies 2018 ·Frontiers in Neurology ·Matěj Škorvánek, Eva Feketeová, Mónica Kurtis, Jan Rusz, Karel Šonka	40
17	Global scales for cognitive screening in Parkinson's disease: Critique and recommendations 2017 ·Movement Disorders ·Matěj Škorvánek, Jennifer G. Goldman, Marjan Jahanshahi, Connie Marras, Irena Rektorová, Ben Schmand, Erik van Duijn, Christopher G. Goetz, Daniel Weintraub, Glenn T. Stebbins, Pablo Martínez‐Martín	152
18	Exploding head syndrome – a rare parasomnia or a dissociative episode? 2014 ·Sleep Medicine ·Eva Feketeová, Jitka Bušková, Matěj Škorvánek, (unknown), Zuzana Gdovinová	9
19	Influence of Disease Severity on Fatigue in Patients with Parkinson's Disease Is Mainly Mediated by Symptoms of Depression 2013 ·European Neurology ·Jitse P. van Dijk, Eva Havlíková, Jaroslav Rosenberger, Iveta Nagyová, Matěj Škorvánek, Zuzana Gdovinová, (unknown), Johan W. Groothoff, Berrie Middel	13
20	Effects of static magnetic field and pulsed electromagnetic field on viability of human chondrocytes in vitro 2007 ·Physiological Research ·(unknown), Matěj Škorvánek, (unknown), Ján Rosocha, (unknown), Ján Sabó	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact